- Home
- FBIO vs BCIC Comparison
FBIO vs BCIC Comparison
Compare FBIO & BCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBIO | BCIC |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.4M | 74.1M |
| IPO Year | 2011 | 2006 |
Fundamental Metrics
Financial Performance| Metric | FBIO | BCIC |
|---|---|---|
| Price | $1.98 | $6.79 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $9.83 |
| AVG Volume (30 Days) | ★ 204.8K | 60.1K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 16.89% |
| EPS Growth | 97.40 | ★ 262.50 |
| EPS | ★ 2.86 | N/A |
| Revenue | ★ $63,262,000.00 | N/A |
| Revenue This Year | $24.55 | N/A |
| Revenue Next Year | $43.73 | N/A |
| P/E Ratio | $0.70 | ★ N/A |
| Revenue Growth | ★ 9.69 | N/A |
| 52 Week Low | $1.79 | $5.78 |
| 52 Week High | $4.53 | $13.44 |
Technical Indicators
Market Signals| Indicator | FBIO | BCIC |
|---|---|---|
| Relative Strength Index (RSI) | 48.32 | 60.28 |
| Support Level | $1.83 | $5.78 |
| Resistance Level | $2.12 | $7.70 |
| Average True Range (ATR) | 0.10 | 0.26 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 68.10 | 82.79 |
Price Performance
Historical ComparisonAbout FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
About BCIC BCP Investment Corporation
BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.